BFAM Partners Cayman Ltd's Q2 2024 13F: no position changes
Form 13F-HR for the quarter ended Jun 30, 2024 · filed Aug 13, 2024 · 1 reported position · accession 0001639101-24-000004
What changed this quarter
No equity positions were opened, closed, increased or reduced in this filing.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
No changes in the top 10 this quarter
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | LAKESHORE BIOPHARMA CO LTD (LSBPW) | 100.0% | 100.0% |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).